ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
17 announcements with these filters
Medico Intercontinental Ltd reported revenue from operations of ₹22.8 Cr (+11.8% YoY) and net profit of ₹0 Cr for Q2 FY27.
Medico Intercontinental has scheduled a board meeting for November 6, 2026 to consider unaudited financial results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after the results.
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Medico Intercontinental Limited conducted its 42nd Annual General Meeting on September 30, 2026. Shareholders considered the adoption of FY26 financial statements and approved several related party transactions.
Medico Intercontinental Ltd will convene its Annual General Meeting on September 30, 2026. The company announced book closure from September 24 to September 30, 2026.
Medico Intercontinental Ltd reported revenue from operations of ₹20.7 Cr (-3.3% YoY) and a net loss of ₹4 Cr for Q1 FY27.
Medico Intercontinental Ltd scheduled a board meeting on August 14, 2026, to consider and approve the unaudited standalone and consolidated financial results for the June quarter.
Promoter Samir Dilipkumar Shah acquired 1,36,886 shares (1.37%) of Medico Intercontinental via open market purchase. Total promoter group holding increased to 60.48%.
Promoter Samir Dilipkumar Shah acquired 1,36,886 shares of Medico Intercontinental via open market. The transaction, valued at Rs. 0.54 Crore, increased his stake to 47.77%.
Medico Intercontinental re-appointed M/s. MJV & Co as Internal Auditors for the 2026-27 financial year. The firm brings extensive audit experience to the company.
Medico Intercontinental Ltd reported revenue from operations of ₹22.5 Cr (+6.1% YoY) and a net loss of ₹2.3 Cr for Q4 FY26.
Medico Intercontinental approved audited FY26 financial results and re-appointed M/s. MJV & Co as internal auditors. The board also reviewed and approved various corporate policies.
Medico Intercontinental Ltd scheduled a board meeting on May 22, 2026, to approve audited financial results. The trading window remains closed until May 24, 2026.
Medico Intercontinental Ltd has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026, as per SEBI Regulation 24A. The report, issued by M/s. AGARWAL & MEHTA COMPANY SECRETARIES LLP, confirms the company's compliance with applicable SEBI regulations and circulars during the period under review.
Medico Intercontinental Ltd submitted its initial disclosure under the SEBI Large Corporate framework, reporting outstanding borrowings of ₹18.00 Crore as of March 31, 2026. The company confirmed it does not meet the criteria to be classified as a Large Corporate (LC) for the financial year.
Medico Intercontinental Ltd reported a net loss of ₹1.7 Cr for Q3 FY26.
Medico Intercontinental Ltd submitted its quarterly compliance certificate under SEBI (DP) Regulations for the period ended March 31, 2026. The registrar, Purva Sharegistry (I) Pvt. Ltd., reported nil share certificates received for dematerialisation during this quarter.